Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

315 related articles for article (PubMed ID: 32787374)

  • 1. A case of durvalumab-treated double primary cancers of the colon and lung.
    Pu X; Xu T; Ge C; He Y; Yang X; Chang P
    Ann Palliat Med; 2020 Sep; 9(5):3614-3622. PubMed ID: 32787374
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Colon metastasis from lung adenocarcinoma with BRAF V600E mutation: A case report.
    Luo Y; Mou K; Wang J; Luo J; Peng L; Ye H; Lin S
    Front Immunol; 2022; 13():970879. PubMed ID: 36003386
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term response with durvalumab after chemoradiotherapy for pulmonary pleomorphic carcinoma: A case report.
    Yorozuya T; Taya T; Yasuda K; Nagano Y; Shioya M; Chiba H; Takahashi H
    Thorac Cancer; 2020 Apr; 11(4):1090-1093. PubMed ID: 32045109
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study.
    Garassino MC; Cho BC; Kim JH; Mazières J; Vansteenkiste J; Lena H; Corral Jaime J; Gray JE; Powderly J; Chouaid C; Bidoli P; Wheatley-Price P; Park K; Soo RA; Huang Y; Wadsworth C; Dennis PA; Rizvi NA;
    Lancet Oncol; 2018 Apr; 19(4):521-536. PubMed ID: 29545095
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IoNESCO trial: Immune neoajuvant therapy in early stage non-small cell lung cancer].
    Mignard X; Antoine M; Moro-Sibilot D; Dayen C; Mennecier B; Gervais R; Amour E; Milleron B; Morin F; Zalcman G; Wislez M
    Rev Mal Respir; 2018 Nov; 35(9):983-988. PubMed ID: 30243521
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Successful treatment of a patient with non-small cell lung cancer and interstitial lung disease with durvalumab: a case report.
    Tao H; Li F; Li R; Han X; Hu Y
    Ann Palliat Med; 2020 Sep; 9(5):3623-3628. PubMed ID: 32648466
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Durvalumab for the treatment of non-small cell lung cancer.
    Mezquita L; Planchard D
    Expert Rev Respir Med; 2018 Aug; 12(8):627-639. PubMed ID: 29958099
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [A Case of Local Recurrence of Descending Colon Cancer with Ileus Obstruction and Lung, Liver and Brain Metastasis].
    Tomita R; Fujisaki S; Sakurai K; Azuhata T; Takamoto Y
    Gan To Kagaku Ryoho; 2018 Apr; 45(4):679-681. PubMed ID: 29650833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical Activity, Tolerability, and Long-Term Follow-Up of Durvalumab in Patients With Advanced NSCLC.
    Antonia SJ; Balmanoukian A; Brahmer J; Ou SI; Hellmann MD; Kim SW; Ahn MJ; Kim DW; Gutierrez M; Liu SV; Schöffski P; Jäger D; Jamal R; Jerusalem G; Lutzky J; Nemunaitis J; Calabrò L; Weiss J; Gadgeel S; Bhosle J; Ascierto PA; Rebelatto MC; Narwal R; Liang M; Xiao F; Antal J; Abdullah S; Angra N; Gupta AK; Khleif SN; Segal NH
    J Thorac Oncol; 2019 Oct; 14(10):1794-1806. PubMed ID: 31228626
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patient-reported outcomes with durvalumab after chemoradiotherapy in stage III, unresectable non-small-cell lung cancer (PACIFIC): a randomised, controlled, phase 3 study.
    Hui R; Özgüroğlu M; Villegas A; Daniel D; Vicente D; Murakami S; Yokoi T; Chiappori A; Lee KH; de Wit M; Cho BC; Gray JE; Rydén A; Viviers L; Poole L; Zhang Y; Dennis PA; Antonia SJ
    Lancet Oncol; 2019 Dec; 20(12):1670-1680. PubMed ID: 31601496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metachronous triple primary neoplasms with primary prostate cancer, lung cancer, and colon cancer: A case report.
    Feng Y; Zhong M; Zeng S; Xiao D; Liu Y
    Medicine (Baltimore); 2018 Jun; 97(26):e11332. PubMed ID: 29953024
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Durvalumab for recurrent or metastatic head and neck squamous cell carcinoma: Results from a single-arm, phase II study in patients with ≥25% tumour cell PD-L1 expression who have progressed on platinum-based chemotherapy.
    Zandberg DP; Algazi AP; Jimeno A; Good JS; Fayette J; Bouganim N; Ready NE; Clement PM; Even C; Jang RW; Wong S; Keilholz U; Gilbert J; Fenton M; Braña I; Henry S; Remenar E; Papai Z; Siu LL; Jarkowski A; Armstrong JM; Asubonteng K; Fan J; Melillo G; Mesía R
    Eur J Cancer; 2019 Jan; 107():142-152. PubMed ID: 30576970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sister Mary Joseph's nodule as a presenting sign of internal malignancy.
    Dodiuk-Gad R; Ziv M; Loven D; Schafer J; Shani-Adir A; Dyachenko P; Rozenman D
    Skinmed; 2006; 5(5):256-8. PubMed ID: 16957443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Durvalumab in non-small-cell lung cancer patients: current developments.
    Mezquita L; Planchard D
    Future Oncol; 2018 Feb; 14(3):205-222. PubMed ID: 29140105
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anlotinib combined with durvalumab in a patient with recurrent multifocal brain metastases of small cell lung cancer after definitive concurrent chemoradiotherapy and palliative radiotherapy of the lung and brain: a case report.
    Wu Y; Zhang T; Liu Y; Wang J; Bi N
    Ann Palliat Med; 2021 Feb; 10(2):2379-2386. PubMed ID: 33725780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [A Case of Complete Response to Computed Tomography-Guided Celiac Plexus Neurolysis of Pain Associated with Postoperative Recurrence of Colon Cancer].
    Yabe N; Masuda M; Tamura E; Morishige S; Saito A; Harada Y; Miyabayashi M; Sakimoto Y; Tajima Y; Takenoya T; Oto I; Yoshikawa T; Osumi K; Murai S
    Gan To Kagaku Ryoho; 2018 Dec; 45(13):1877-1879. PubMed ID: 30692384
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case Report: A case of advanced duodenal adenocarcinoma in complete remission after chemotherapy combined with targeted therapy and radiotherapy.
    Zhang Z; Lei Y; Wang D; Yang L; Lou C
    Front Oncol; 2022; 12():968110. PubMed ID: 36353566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Recurrent rectal cancer with multiple liver and lung metastases treated effectively with oxaliplatin and capecitabine plus bevacizumab chemotherapy-a case report].
    Yabe N; Murai S; Shimizu H; Kitasato K; Yoshikawa T; Oto I; Nakadai J; Hasegawa H; Kitagawa Y
    Gan To Kagaku Ryoho; 2013 Nov; 40(12):1834-6. PubMed ID: 24393938
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Safety and antitumour activity of durvalumab plus tremelimumab in non-small cell lung cancer: a multicentre, phase 1b study.
    Antonia S; Goldberg SB; Balmanoukian A; Chaft JE; Sanborn RE; Gupta A; Narwal R; Steele K; Gu Y; Karakunnel JJ; Rizvi NA
    Lancet Oncol; 2016 Mar; 17(3):299-308. PubMed ID: 26858122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A Phase Ib Trial of Durvalumab in Combination with Trastuzumab in HER2-Positive Metastatic Breast Cancer (CCTG IND.229).
    Chia S; Bedard PL; Hilton J; Amir E; Gelmon K; Goodwin R; Villa D; Cabanero M; Tu D; Tsao M; Seymour L
    Oncologist; 2019 Nov; 24(11):1439-1445. PubMed ID: 31420468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.